Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134655) titled 'Perioperative Prehabilitation Program for Lung Cancer Patients Receiving Immunotherapy' on Oct. 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking University People's Hospital
Condition:
lung cancer
Intervention:
Control group:Usual Preoperative Care
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-10-26
Target Sample Size: Control group:45;experimental group:45;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=347092
Disclaimer: Curated by HT Syndication....